MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
8.97
-0.11
-1.21%
After Hours: 8.97 0 0.00% 17:13 07/13 EDT
OPEN
9.16
PREV CLOSE
9.08
HIGH
9.22
LOW
8.88
VOLUME
2.87M
TURNOVER
--
52 WEEK HIGH
20.46
52 WEEK LOW
7.21
MARKET CAP
2.08B
P/E (TTM)
13.22
1D
5D
1M
3M
1Y
5Y
1D
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
NASDAQ · 10h ago
Weekly Report: what happened at ADMA last week (0706-0710)?
Weekly Report · 14h ago
ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
PR Newswire · 15h ago
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR Newswire · 23h ago
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire · 4d ago
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
NASDAQ · 4d ago
INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
PR Newswire · 4d ago
Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
PR Newswire · 5d ago
More
About ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.